BMBF-Symposium "Medi-WING"

Time Wednesday, June 30, 2010: 1st Congress Day
  8:30Registration and Exhibition
10:00Plenary Session: Innovation in Medicine

13:00Lunch Break at the Exhibition



Bioactive Implants I

Welcome and Introduction
Representative of the Federal Ministry of Education and Research, Bonn

Cardiovascular Applications of Bioactive Implants (RNA-Stent)
Manfred Gülcher, Managing Director, QualiMed Innovative Medizinprodukte GmbH, Winsen (Luhe)

Bioactive Joint Implants (Bio-Integration)
Dr. Bernhard Kleffner, Head of R&D, Peter Brehm GmbH Chirurgie Mechanik, Weisendorf

15:45Coffee Break at the Exhibition



Bioactive Implants II

New Biomaterials for Ophthalmologic Applications (BioThermGel)
Dr. Christian Lingenfelder, General Manager, Fluoron GmbH, Ulm

Bioactive Soft Tissue Implants (BioInside)
Prof. Dr. Raimund W. Kinne, Head of Experimental Rheumatology Unit, University Hospital Jena

From Development to New Products: Regulatory Framework of Medical Device / Medicinal Product Combinations
Dr. Christian Schübel, Head of Clinical Aff airs, TÜV SÜD Product Service GmbH, Munich

18:00Get Together at the Exhibition
19:30Official Reception at Kaiserburg Nuremberg

TimeThursday, July 1, 2010: 2nd Congress Day
  8:00Breakfast at the Exhibition



Molecular Imaging - From Invention to Innovation

Welcome and Introduction

Molecular Imaging - Status Quo and Capabilities from the Science Point of View
Prof. Dr. Markus Schwaiger, Director of Nuclear Medicine, Klinikum rechts der Isar, Dean of Medical Faculty, Technical University of Munich

Impact of Molecular Imaging for a Qualitatively High Value and Affordable Health Care System
Prof. Dr. Hans Maier, Head of Business Unit Diagnostic Imaging, Bayer Schering Pharma AG, Berlin

Mutual Impact of Molecular Imaging and the Medical Device Industry
Britta Fünfstück, CEO Molecular Imaging, Siemens AG Healthcare Sector, Hoffman Estates, IL, USA

Quantum Dots in Molecular Imaging: From Technological Fascination to Clinical Reality
Dr. Christoph Block, CEO/CSO, Signalomics GmbH, Steinfurt

11:15Lunch Break at the Exhibition
12:45 Technology Initiative Molecular Imaging

Targeted PET-Tracer and MR Contrast Agents for Monitoring of Tumor Th erapies
Dr. Gunnar Schütz, Diagnostic Imaging Research, Bayer Schering Pharma AG, Berlin

PET-Diagnostic Imaging of Tumors with New Recombinant Vaccinia Viruses
Dr. Albert Röder, CEO, Genelux GmbH, Bernried

Optical Molecular Imaging for Diagnosis of Alzheimer and Macula Degeneration in the Eye
Dr. Christoph Russmann, Manager Clinical Affairs, Carl Zeiss Meditec AG, Jena

Molecular Imaging in Endoscopy
Dr. Norbert Hansen, Project Manager, Karl Storz GmbH & Co. KG, Tuttlingen

Magnetic Particle Imaging - a New Imaging Modality and its Potential for Molecular Imaging
Dr. Michael Kuhn, Vice President Technology Strategy, Philips Healthcare, Hamburg

15:30Plenary Session: Strategies & Visions



Get Together at the Exhibition

Cookies facilitate the provision of our services. By using our services, you agree that we may use cookies.
Privacy Policy